Share page with colleagues
Archives
Blog Archives
Adaptive Partners with BMS on Cancer Immunotherapy Program
Today, Adaptive announced a partnership with Bristol Myers Squibb for the discovery of immunological biomarkers in cancer. The announcement was even picked up by the Wall Street Journal, whose press release can be read here. BMS is a pioneer and … Continue reading
View similar posts in Announcements, News, Newsworthy, Press Release
Press Release: New Study Shows Adaptive Biotechnologies immunoSEQ Assay Significantly More Sensitive than Traditional Method to Detect Minimal Residual Disease in Leukemia
Adaptive Biotechnologies, Fred Hutchinson Cancer Research Center, and University of Washington Study Demonstrates Clinical Utility of Next-Generation Immune Profiling Technology SEATTLE, WA, May 16, 2012 – Adaptive Biotechnologies Corporation, a leading provider of next-generation sequencing assays for the adaptive immune … Continue reading
View similar posts in Announcements, Press Release
Adaptive TCR Co-Founders Receive $1 Million Grant from W.M. Keck Foundation for Human Immune Profiling Research
SEATTLE, April 8, 2011 — Adaptive TCR co-founders, Harlan Robins, Ph.D., and Chris Carlson, Ph.D., received a $1 million grant from the W.M. Keck Foundation to pursue an ambitious project to sequence DNA from the human immune system to shed … Continue reading
View similar posts in Home Page, Newsworthy, Press Release
Adaptive TCR launches the immunoSEQ™ product line – visualizing the immune system with next-generation sequencing.
Seattle, WA – Adaptive TCR Technologies, a biotech firm based in Seattle, WA, announced today the release of its immunoSEQ™ profiling service and immunoSEQ Analyzer™ bioinformatics software platform. Together, these tools provide researchers and clinicians the ability to profile and … Continue reading
View similar posts in Home Page, Newsworthy, Press Release
ImmunoSEQ analysis reveals highly unexpected T cell similarities
Seattle, WA September 3, 2010 — A new study published in Science Translational Medicine highlights the kind of important insight that can be gained from an application of the immunoSEQTM immune system profiling technology. The study was authored by Harlan … Continue reading
View similar posts in Home Page, Newsworthy, Press Release
Adaptive TCR Partners with Fred Hutchinson Cancer Center in LSDF Grant
Seattle, WA — Dr. Harlan Robins, Fred Hutchinson Cancer Research Center, has been awarded a grant of $150,000 from the Life Science Discovery Fund for the development of high-throughput sequencing strategies aimed at T cell receptors. This competitive award represents … Continue reading
View similar posts in Home Page, Newsworthy, Press Release
